Lithoz ceramic 3D printing revenue jumps 40 percent as customers scale up

Ceramic printing is quietly moving off the bench

Lithoz, the Vienna based specialist in ceramic additive manufacturing, says its materials revenue climbed 40 percent year over year. The company points to service bureaus and medical firms as the main drivers of that Q2 growth. It is a useful signal. When material sales rise, it usually means machines already installed on customer floors are running more often and at higher volume.

A small group of customers does most of the work

Lithoz notes that 20 percent of its customers operate roughly half of all CeraFab systems worldwide. On the surface that looks like risky customer concentration. The company frames it differently: those operators are becoming specialized ceramic manufacturing partners that keep adding machines as they scale. Either way, the installed base is deepening rather than just widening.

Where the growth actually shows up

Three material families lead the expansion. Aluminum nitride is finding use in electronics and heat management. Silica based ceramics show up in casting cores. Calcium phosphates feed medical work such as bone replacement and resorbable implants. That spread matters because it pulls Lithoz away from the usual dependence on alumina and zirconia, and it puts the company into three very different industries at once.

Contrast that with the laser powder bed fusion crowd, which has leaned heavily on titanium orthopedic implants for years. Titanium is a good business with solid economics, but a single application concentration is fragile. Lithoz gets exposure to consumer electronics, semiconductors, and aerospace cooling instead, which is a more balanced position if one sector cools.

The certification milestone

CEO Johannes Homa says the bigger recent win was reaching ISO 13485 certification for the company quality management in material production. In his words, the team has developed a good number of customized materials for customers now scaling their production to higher volumes, and the certification proved to be a powerful door opener into tightly regulated industries. For medical and aerospace buyers, that paperwork is often the difference between a pilot and a purchase order.

What comes next

Lithoz is betting on resorbable ceramic implants as a long term growth area. The pitch is appealing: an implant that does its job and then dissolves when no longer needed, sometimes built patient specific. The catch is time. Titanium implants took about 30 years to become routine in spinal, knee, and hip work, so ceramic resorbables have a long road ahead.

The company also sees upside in semiconductor tooling and data center cooling, two areas where money is flowing fast right now. Those markets are cyclical and can turn quickly, but they give Lithoz room to grow while the rest of the industry piles into defense contracts. For a materials led ceramics player, that diversification looks like the right kind of insurance.